Stay updated on Lorlatinib in ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib in ROS1+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:13:24.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T05:56:09.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The date for an event has been updated from March 28, 2024, to May 2, 2025.
    Difference
    1.0%
    Check dated 2025-05-07T19:22:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:57:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the core content.
    Difference
    1.0%
    Check dated 2025-04-16T02:11:17.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-08T23:43:55.000Z thumbnail image

Stay in the know with updates to Lorlatinib in ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib in ROS1+ NSCLC Clinical Trial page.